Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Feige

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Immunology|January 1, 1992
Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat shock protein: specificity and mechanismX D Yang, J Gasser, U Feige
Experientia|July 5, 1993
Interleukin-8 is a cyclosporin A binding proteinH Bang, K Brune, C Nager, et al.
Immunobiology|January 1, 1982
Use of a multiwell assembly for chemotaxis and evaluation by enzyme-linked immunosorbent assay (ELISA)C Sorg, C Ramb, B Overwien, et al.
Molecular Immunology|March 1, 1983
Characterization of human lymphocyte derived chemotactic factors for mononuclear phagocytes--I. Production and detectionC Ramb, U Malorny, U Feige, et al.
Journal of Virology|September 1, 1975
Escherichia coli capsule bacteriophages. VII. Bacteriophage 29-host capsular polysaccharide interactionsF Fehmel, U Feige, H Niemann, et al.
International Journal of Tissue Reactions|January 1, 1989
Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-jointU Feige, A Karbowski, C Rordorf-Adam, et al.
Journal of Bacteriology|January 1, 1981
Structure of the heptose region of lipopolysaccharies from Rhodospirillum tenueJ Radziejewska-Lebrecht, U Feige, H Mayer, et al.
Journal of Autoimmunity|February 1, 1990
Treatment of adjuvant arthritis in rats: vaccination potential of a synthetic nonapeptide from the 65 kDa heat shock protein of mycobacteriaX D Yang, J Gasser, B Riniker, et al.
Autoimmunity|January 1, 1994
A constitutive 65 kDa chondrocyte protein as a target antigen in adjuvant arthritis in Lewis ratsU Feige, A Schulmeister, J Mollenhauer, et al.
Current Opinion in Rheumatology|May 3, 2001
Anti-interleukin-1 therapy in rheumatic diseasesJ M Dayer, U Feige, C K Edwards, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|January 1, 1992
Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat shock protein: specificity and mechanismX D Yang, J Gasser, U Feige
Experientia|July 5, 1993
Interleukin-8 is a cyclosporin A binding proteinH Bang, K Brune, C Nager, et al.
Immunobiology|January 1, 1982
Use of a multiwell assembly for chemotaxis and evaluation by enzyme-linked immunosorbent assay (ELISA)C Sorg, C Ramb, B Overwien, et al.
Molecular Immunology|March 1, 1983
Characterization of human lymphocyte derived chemotactic factors for mononuclear phagocytes--I. Production and detectionC Ramb, U Malorny, U Feige, et al.
Journal of Virology|September 1, 1975
Escherichia coli capsule bacteriophages. VII. Bacteriophage 29-host capsular polysaccharide interactionsF Fehmel, U Feige, H Niemann, et al.
International Journal of Tissue Reactions|January 1, 1989
Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-jointU Feige, A Karbowski, C Rordorf-Adam, et al.
Journal of Bacteriology|January 1, 1981
Structure of the heptose region of lipopolysaccharies from Rhodospirillum tenueJ Radziejewska-Lebrecht, U Feige, H Mayer, et al.
Journal of Autoimmunity|February 1, 1990
Treatment of adjuvant arthritis in rats: vaccination potential of a synthetic nonapeptide from the 65 kDa heat shock protein of mycobacteriaX D Yang, J Gasser, B Riniker, et al.
Autoimmunity|January 1, 1994
A constitutive 65 kDa chondrocyte protein as a target antigen in adjuvant arthritis in Lewis ratsU Feige, A Schulmeister, J Mollenhauer, et al.
Current Opinion in Rheumatology|May 3, 2001
Anti-interleukin-1 therapy in rheumatic diseasesJ M Dayer, U Feige, C K Edwards, et al.
Pageof 4